Cedric Francois
Director, Chief Executive Officer · 6 filings · Latest: May 14, 2026
Apellis Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
APLS | Cedric Francois | Director, Chief Executive Officer | Feb 3, 2026 | Option Exercise | $3.76 | 8,840 | $33.2K | 490,837 | |
APLS | Cedric Francois | Director, Chief Executive Officer | Jan 22, 2026 | Sale | $21.77 | 27,192 | $591.8K | 286,045 | |
APLS | Francois Cedric | — | Jan 22, 2026 | Proposed Sale | $21.77 | 27,192 | $591.8K | — | |
APLS | Cedric Francois | Director, Chief Executive Officer | Jan 20, 2026 | Sale | $19.79 | 8,182 | $161.9K | 313,237 | |
APLS | Francois Cedric | — | Jan 20, 2026 | Proposed Sale | $19.79 | 8,182 | $161.9K | — | |
APLS | Francois Cedric | — | Jan 13, 2026 | Proposed Sale | $22.19 | 10,186 | $226.0K | — | |
APLS | The Cedric Francois Irrevocable Trust of 2023 - 2 DTD 4/6/2023 | — | Aug 27, 2025 | Proposed Sale | $28.72 | 225,000 | $6.5M | — | |
APLS | Francois Cedric | — | Jul 17, 2025 | Proposed Sale | $20.15 | 19,725 | $397.6K | — | |
APLS | Francois Cedric | — | Jul 15, 2025 | Proposed Sale | $20.09 | 1,900 | $38.2K | — | |
APLS | Francois Cedric | — | Jul 14, 2025 | Proposed Sale | $20.19 | 137,465 | $2.8M | — | |
APLS | Francois Cedric | — | Jan 29, 2025 | Proposed Sale | $29.52 | 2,824 | $83.4K | — | |
APLS | Francois Cedric | — | Jan 22, 2025 | Proposed Sale | $30.43 | 13,551 | $412.3K | — | |
APLS | Francois Cedric | — | Jan 17, 2025 | Proposed Sale | $29.96 | 6,007 | $180.0K | — | |
APLS | Francois Cedric | — | Jan 13, 2025 | Proposed Sale | $28.70 | 6,357 | $182.4K | — |